Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kinross Gold Corporation (KGC) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Kinross Gold CorporationTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Kinross Gold Corporation vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Kinross Gold Corporation trades at $22.46 (market cap $27.68B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Kinross Gold Corporation is far larger — about 2.6× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Kinross Gold Corporation pays the higher dividend (0.68%). Which is the better fit depends on your goals — on Pluang, investors hold Kinross Gold Corporation for 53 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

KGCRDY
Market Cap
$27.68B$10.78B
Volume
5,395,4042,724,343
Sector
Basic MaterialsHealth
52-Week High
$38.06$15.38
52-Week Low
$22.24$11.38
Typical Hold Time
53 Days0 Days
Enterprise Value
$25.76B$10.68B
Dividend Yield
0.68%0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kinross Gold Corporation

Kinross Gold (KGC) trades at $22.24, down 5.56% amid production guidance cuts and legal investigations, yet maintains strong fundamentals with robust earnings beats and a 37.52% net margin. Technical indicators show bearish momentum with support at $23, while fundamentals reveal impressive revenue growth from $3.5B in 2022 to $7.05B in 2025, supported by a low P/E of 8.91 and rising cash flow.

The stock presents a value opportunity with a consensus price target of $38.80 (74% upside), but faces near-term headwinds from operational setbacks and legal scrutiny. Long-term prospects remain solid due to gold price strength and shareholder returns, though investors must weigh production risks against valuation appeal.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KGC
32% Buy68% Sell
Avg holding period · 53 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Kinross Gold Corporation

Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.

Read more on KGC →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →